This really is a two-party negotiation between a government agency and also a pharmaceutical company to decide if a brand new medicine will be put on the compensation list.
The pharmaceutical company has a valuable new merchandise, the authorities has semi-monopolistic power over whether (or not) drugs are listed. The role-play allows participants to negotiate given the built-in worth-creation limits of the setting.
Pulmocit (A) Negotiating Pharmaceutical Products with the Government Case Study Solution
PUBLICATION DATE: January 27, 2014 PRODUCT #: INS387-HCB-ENG
This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE
Related Case Solutions & Analyses:
Human Resources at Hewlett-Packard (A)
Ken Private Limited: Digitization Project
IP Modularity: Profiting from Innovation by Aligning Product Architecture with Intellectual Property
Managing the Intellectual Property Disassembly Problem
The Educator’s Dilemma: Engaging Students in Knowledge Creation
Mahindra & Mahindra in South Africa
Leadership is Not What You Think: A Socratic Dialogue
Anne Livingston and Power Max Systems (E1): Livingston Takes Formal Authority
AMB Consolidation
Guaranty Trust Bank PLC Nigeria (A)
